About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNANCT06965790

Study on Sex-specific, Individualized Dose Calculation of Contrast Agent in CT Examinations

A large proportion of radiological CT examinations require the intravenous administration of iodine-containing X-ray contrast medium. According to current guidelines, the amount required for CT examin...

Lead sponsor: University Hospital Augsburg•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Claudia Wollny, Dr.

CONTACT

0049 (0) 821 400 radiologie-studien@uk-augsburg.de

Sponsors

Lead Sponsor

University Hospital Augsburg

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Presence of a justifying indication for a CT scan of the thorax and abdomen with application of intravenous contrast medium and a start delay corresponding to the portal venous contrast medium phase
•Ability to give informed consent, as well as written and verbal consent to participate in the study available

Exclusion Criteria

•Cardiorespiratory instability (as assessed by the attending physician)
•Age \<18 years
•Existing or suspected pregnancy
•Known post hepatectomy and/or splenectomy
•Lack of current height (in the same inpatient/outpatient hospital stay) or lack of possibility of height measurement
•Lack of current daily body weight or inability to measure body weight
•Height under 140 cm or over 220 cm
•Body weight under 50 kg or over 120 kg
•Contraindication to iodine-containing contrast medium (Allergy to contrast media containing iodine, Severe renal insufficiency (eGFR \< 30 ml/min), Hyperthyroidism)

Related studies

The Effect of Gender-affirmative Measures on Breast Perception in Trans Men

NCT07252687 · Transgender, Gender Dysphoria in Adolescents and Adults

What Works - Malawi SASA! Together

NCT06783400 · Intimate Partner Violence (IPV), Norms, Social, and more

Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy

NCT07147166 · Gender Dysphoria, Mastectomy, and more

Gynaecological Care for Transgender People in France in 2024.

NCT06357130 · Transgender Management Care

RECRUITINGPhase 2

Progesterone in Gender Affirming Hormone Therapy Study

NCT06807580 · Transgender Women

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 9, 2025Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment400

Start dateApr 2025

Last updatedDec 9, 2025

Condition

CT Scans Contrast Media Gender Womens Health

Locations shown

University Hosptial Augsburg

Augsburg, Bavaria

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 9, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions